
Overview
Ultrasonic coating systems maker's Q3 revenue fell 4% yr/yr, missing analyst expectations
Company's gross margin expanded to 50% in qtr, reflecting improved operational efficiency
Company's backlog reached record $12.3 mln, indicating strong customer order momentum
Outlook
Sono-Tek reiterates FY 2026 guidance, anticipating modest revenue growth
Company expects growing demand in medical device market to offset clean energy declines
Sono-Tek sees evolving tariff policies impacting future results
Result Drivers
MEDICAL MARKET - Continued strength in the medical market drove demand for ultrasonic coating platforms, supporting revenue above $5 million for the seventh consecutive quarter
HIGH-ASP SYSTEMS - Focus on high-ASP production systems contributed to gross margin expansion to 50%
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | Miss | $5.004 mln | $5.24 mln (2 Analysts) |
Q3 Net Income |
| $340,000 |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the industrial machinery & equipment peer group is "buy"
Wall Street's median 12-month price target for Sono-Tek Corp is $7.75, about 85.4% above its January 12 closing price of $4.18
Press Release: ID:nGNXbYZkvt
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.